Disagree
Home Driada Medical Driada Medical
Myostane
Myostane - Driada Medical

Myostane - Driada Medical

Brand:
Category:
Substance:
Dosage:
5 mg/tab
Package:
50 tablets
Price:
$47.00 - $49.00
See options
Product Overview

As a SARM, YK-11 is designed to selectively stimulate muscle and bone tissue growth while limiting effects on other organs. This compound stands out from other SARMs due to its steroidal structure, allowing it to partially mimic anabolic steroids’ muscle-enhancing effects but with selective androgen receptor targeting that limits unwanted androgenic effects in the body. Studies have shown YK-11’s capability to increase follistatin levels, which inhibits myostatin—a known muscle growth inhibitor—suggesting it could support lean muscle mass development. Typically used in 4 to 8-week cycles, users may take YK-11 at doses ranging from 5 to 10 mg per day, though reliable information on half-life and long-term safety is still unavailable due to the lack of clinical trials​.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Myostane by Driada Medical, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
How does YK-11 promote muscle growth?
It promotes muscle growth by increasing follistatin levels, a natural inhibitor of myostatin, allowing for greater muscle development.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What is the recommended dosage for YK-11?
Typical cycles range from 5 to 10 mg per day for about 4 to 8 weeks, though these doses are based on limited studies and anecdotal use.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Are there known side effects of YK-11?
While the androgenic side effects appear lower, users have reported potential impacts on cholesterol levels, and further research is needed to confirm its full safety profile.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.